Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)
CNY 7.93
(0.38%)
CNY 7.93
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.06 Billion | 886.57 Million | 758.16 Million | 632.69 Million | 921.12 Million | 884.97 Million |
| Cost of Revenue | 467.98 Million | 451.83 Million | 356.07 Million | 327.08 Million | 374.5 Million | 363.84 Million |
| Gross Profit | 599.22 Million | 434.73 Million | 402.08 Million | 305.6 Million | 546.61 Million | 521.13 Million |
| Operating Expenses | 305.95 Million | 215.71 Million | 219 Million | 195.38 Million | 309.18 Million | 307.8 Million |
| Selling, General and Administrative Expenses | 216.19 Million | 127.09 Million | 131.68 Million | 112.87 Million | 224.16 Million | 220.05 Million |
| Research and Development Expenses | 48.9 Million | 38 Million | 37.77 Million | 36.49 Million | 44.38 Million | 46.62 Million |
| Other Expenses | 93.79 Million | 50.6 Million | 49.54 Million | 46.01 Million | 40.63 Million | -4.75 Million |
| Cost and Expenses | 773.94 Million | 667.54 Million | 575.07 Million | 522.47 Million | 683.69 Million | 671.64 Million |
| Operating Income | 306.62 Million | 196.54 Million | 201.42 Million | 121.74 Million | 197.57 Million | 181.91 Million |
| Interest Expense | 16.36 Million | 29.13 Million | 29.51 Million | 42.71 Million | 46.21 Million | 40.78 Million |
| Income Tax Expense | 39.81 Million | 18.12 Million | 20.18 Million | 9.46 Million | 25.14 Million | 21.6 Million |
| Earnings before Tax | 292.99 Million | 196.32 Million | 147.09 Million | 53.27 Million | 196.85 Million | 177.15 Million |
| Net Income | 253.17 Million | 178.2 Million | 126.91 Million | 43.81 Million | 171.71 Million | 155.54 Million |
| Earnings Per Share Basic | 0.55 | 0.57 | 0.41 | 0.15 | 0.61 | 0.56 |
| Earnings Per Share Diluted | 0.55 | 0.57 | 0.41 | 0.15 | 0.60 | 0.56 |
| Weighted Average Shares Outstanding | 460.31 Million | 311.85 Million | 310.3 Million | 284.92 Million | 282.81 Million | 279.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 460.31 Million | 311.85 Million | 310.3 Million | 284.92 Million | 286.18 Million | 279.18 Million |
| Gross Margin | 0.56 | 0.49 | 0.53 | 0.48 | 0.59 | 0.59 |
| EBIT Margin | 0.35 | 0.32 | 0.33 | 0.27 | 0.31 | 0.30 |
| Profit Margin | 0.24 | 0.20 | 0.17 | 0.07 | 0.19 | 0.18 |
| EBITDA | 369.46 Million | 277.98 Million | 228.31 Million | 147.59 Million | 269.43 Million | 260.19 Million |
| Earnings Before Tax Margin | 0.29 | 0.22 | 0.27 | 0.19 | 0.21 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 141.84 Million | 147.39 Million | 163.05 Million | 317.41 Million | 1.05 Billion | 206.91 Million |
| Cost of Revenue | 89 Million | 105.44 Million | 91.71 Million | 160.03 Million | 496.53 Million | 93.25 Million |
| Gross Profit | 52.84 Million | 41.94 Million | 71.33 Million | 157.38 Million | 558.39 Million | 113.65 Million |
| Operating Expenses | 52.96 Million | 53.69 Million | 63.23 Million | 76.51 Million | 251.76 Million | 71.43 Million |
| Selling, General and Administrative Expenses | 74.52 Million | 44.12 Million | 52.13 Million | 67.05 Million | - | 82.23 Million |
| Research and Development Expenses | 12.17 Million | 9.57 Million | 11.1 Million | 9.46 Million | - | 12.59 Million |
| Other Expenses | -33.73 Million | -336.67 Thousand | -119.01 Thousand | 4340.00 | 3.45 Million | -4.16 Million |
| Cost and Expenses | 141.96 Million | 159.14 Million | 154.95 Million | 236.54 Million | 748.3 Million | 164.69 Million |
| Operating Income | 1.28 Million | -11.74 Million | 8.09 Million | 80.87 Million | 306.62 Million | 40.7 Million |
| Interest Expense | 635.84 Thousand | 1.98 Million | 1.38 Million | 2.33 Million | 16.8 Million | 4.48 Million |
| Income Tax Expense | -2.22 Million | -3.63 Million | 2.03 Million | 8.59 Million | 39.81 Million | 4.26 Million |
| Earnings before Tax | 1.09 Million | -10.09 Million | 11.19 Million | 73.29 Million | 292.99 Million | 40.62 Million |
| Net Income | 3.32 Million | -6.46 Million | 9.15 Million | 64.69 Million | 253.17 Million | 36.35 Million |
| Earnings Per Share Basic | 0.01 | -0.01 | 0.02 | 0.18 | - | 0.11 |
| Earnings Per Share Diluted | 0.01 | -0.01 | 0.02 | 0.18 | - | 0.11 |
| Weighted Average Shares Outstanding | 510.19 Million | 510.18 Million | 427.21 Million | 359.4 Million | 328.79 Million | 341.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 510.19 Million | 510.18 Million | 427.21 Million | 359.4 Million | 328.79 Million | 341.19 Million |
| Gross Margin | 0.37 | 0.28 | 0.44 | 0.50 | 0.53 | 0.55 |
| EBIT Margin | 0.01 | 0.03 | 0.07 | 0.31 | - | 0.22 |
| Profit Margin | 0.02 | -0.04 | 0.06 | 0.20 | 0.24 | 0.18 |
| EBITDA | 1.73 Million | 4.23 Million | 11.04 Million | 96.92 Million | - | 45.35 Million |
| Earnings Before Tax Margin | 0.01 | -0.08 | 0.05 | 0.25 | 0.29 | 0.20 |
ADEN
GNTA
TTZ
2157
TPS
TIG